thymidine has been researched along with Prostatic Neoplasms in 113 studies
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After transplantation of rat prostate adenocarcinoma cells, dynamic PET measurements with fluorine-18-labeled 2-fluoro-2-deoxy-D-glucose (18FDG) were performed in 15 animals before and 1 day after therapy with 90 mg/kg of body weight (n = 8) and 180 mg/kg of body weight (n = 7) gemcitabine." | 7.69 | PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine. ( Altmann, A; Bellemann, ME; Blatter, J; Brix, G; Doll, J; Gerlach, L; Haberkorn, U; Morr, I; Oberdorfer, F; van Kaick, G, 1997) |
| "The thymidine labeling index (TLI) was measured in vitro in the epithelium and stroma of benign prostate glands and seminal vesicles and in the epithelium of prostatic adenocarcinomas." | 7.66 | Proliferative activity of benign human prostate, prostatic adenocarcinoma and seminal vesicle evaluated by thymidine labeling. ( Martin, SA; Meyer, JS; Sufrin, G, 1982) |
| "After transplantation of rat prostate adenocarcinoma cells, dynamic PET measurements with fluorine-18-labeled 2-fluoro-2-deoxy-D-glucose (18FDG) were performed in 15 animals before and 1 day after therapy with 90 mg/kg of body weight (n = 8) and 180 mg/kg of body weight (n = 7) gemcitabine." | 3.69 | PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine. ( Altmann, A; Bellemann, ME; Blatter, J; Brix, G; Doll, J; Gerlach, L; Haberkorn, U; Morr, I; Oberdorfer, F; van Kaick, G, 1997) |
| "The effects of exogenously added urokinase type plasminogen activator, tissue type plasminogen activator, plasmin and thrombin on the proliferation of primary cultures of cells derived from prostatic hyperplasia or prostatic carcinomas were investigated by measuring the incorporation of 3H-thymidine into the cultures." | 3.67 | Effect of urokinase on the proliferation of primary cultures of human prostatic cells. ( Binder, BR; Christ, G; Heger, ME; Hienert, G; Kirchheimer, JC; Pflüger, H; Wojta, J, 1987) |
| "The thymidine labeling index (TLI) was measured in vitro in the epithelium and stroma of benign prostate glands and seminal vesicles and in the epithelium of prostatic adenocarcinomas." | 3.66 | Proliferative activity of benign human prostate, prostatic adenocarcinoma and seminal vesicle evaluated by thymidine labeling. ( Martin, SA; Meyer, JS; Sufrin, G, 1982) |
| " Because the guanylate cyclase-cyclic GMP system is though to be involved in cell growth, DNA and RNA synthesis, and possible malignant transformation, we examined the effect of the aqueous extract containing GCI on an undifferentiated adenocarcinoma of the rat prostate and concanavalin-A-stimulated [3H]thymidine incorporation into cultured splenic lymphocytes, a process thought to be mediated by cyclic GMP." | 3.66 | Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata). ( Bagwell, CB; Block, NL; Claflin, AJ; Fletcher, MA; Hudson, JL; Lehotay, DC; Levey, GS; Lo, TM; Vesely, DL, 1978) |
| "However, in the case of breast and prostate cancer sera, TK 210 ELISA had higher sensitivity (59% and 44%) compared to [3H]-dThd phosphorylation assay (47% and 25%) at a specificity of 98%." | 1.72 | Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples. ( J, O; Jagarlamudi, KK; L, S; M, Z; P, V; S, E, 2022) |
| "The results in human prostate cancer cell lines demonstrate the presence of ATIP in both cell lines examined, and suggest that (i) the AT(2)-receptor through an interaction with ATIP mediates an anti-growth factor effect in both androgen-dependent and androgen-independent cell lines; (ii) ATIP expression decreases as the rate of cell growth and androgen-independence increase; and (iii) EGF may act on cell growth in part by reducing the content of ATIP present in the cells." | 1.36 | Expression and function of ATIP/MTUS1 in human prostate cancer cell lines. ( Catt, KJ; Chow, L; Frauman, AG; Krezel, MA; Louis, SN; Louis, WJ; Rezmann, L; Tikellis, C, 2010) |
| "BRCA2 protein depletion after cancer cell adhesion to COL1 or in small RNA interference assays triggers new DNA synthesis, a trophic effect that is abrogated by recombinant BRCA2 expression." | 1.33 | Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation. ( Arbini, AA; Greco, M; Marra, E; Moro, L, 2005) |
| " Tocopherols and saponins extracted from argan tree and 2-methoxyestradiol exhibit a dose-response cytotoxic effect and an antiproliferative action on the tested cell lines." | 1.33 | Tocopherols and saponins derived from Argania spinosa exert, an antiproliferative effect on human prostate cancer. ( Adlouni, A; Bennani, H; Charrouf, Z; Drissi, A; Fiet, J; Giton, F, 2006) |
| "Prostate cancer is an androgen-dependent disease; metastatic prostate cancer is typically treated by androgen receptor (AR) blockade." | 1.33 | Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. ( Agoulnik, IU; Alvarado, M; Ayala, GE; Bingman, WE; Erdem, H; Frolov, A; Ittmann, MM; Nakka, M; Smith, CL; Vaid, A; Weigel, NL, 2006) |
| "Bone metastases from prostate cancer cause abnormal new bone formation, however, the factors involved and the pathways leading to the response are incompletely defined." | 1.32 | IGF-I and MAP kinase involvement in the stimulatory effects of LNCaP prostate cancer cell conditioned media on cell proliferation and protein synthesis in MC3T3-E1 osteoblastic cells. ( Bhattacharyya, RS; Stern, PH, 2003) |
| " We performed pharmacokinetic measurements with [(14)C]FMAU and PET studies with [(11)C]FMAU using rats bearing several different syngeneic tumors." | 1.32 | Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats. ( Alauddin, MM; Bading, JR; Bathija, P; Conti, PS; Fissekis, JD; Koda, RT; Koszalka, GW; Shahinian, AH; Vail, A, 2004) |
| " Therefore, we have investigated the effects of the orally bioavailable Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG) on the radiosensitivity of human tumor cells in vitro and grown as tumor xenografts." | 1.32 | Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin. ( Brady, KJ; Bull, EE; Burgan, WE; Camphausen, K; Carter, DJ; Cerra, MA; Dote, H; Hollingshead, MG; Oswald, KA; Tofilon, PJ, 2004) |
| "Juvenile Batten disease is a neurodegenerative disease caused by accelerated apoptotic death of photoreceptors and neurons attributable to defects in the CLN3 gene." | 1.31 | The CLN3 gene is a novel molecular target for cancer drug discovery. ( Amalfitano, A; Boustany, RM; Chang, J; Guo, WX; Jansen, PJ; Persaud-Sawin, DA; Proia, AD; Rylova, SN, 2002) |
| "Melatonin did not suppress and even slightly enhanced the capacity of AR binding to the ARE in the PC3-AR as well as in LNCaP cells." | 1.31 | Differential regulation by melatonin of cell growth and androgen receptor binding to the androgen response element in prostate cancer cells. ( Lupowitz, Z; Rimler, A; Zisapel, N, 2002) |
| " [3H]Thymidine incorporation displayed a bell-shaped dose-response curve in both strains." | 1.30 | LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids. ( Esquenet, M; Heyns, W; Swinnen, JV; Verhoeven, G, 1997) |
| "Four human prostate cancer cell lines were studied." | 1.30 | Expression of gonadotropin-releasing hormone (GnRH) and GnRH receptor mRNA in prostate cancer cells and effect of GnRH on the proliferation of prostate cancer cells. ( Bahk, JY; Cho, GJ; Choi, WS; Hyun, JS; Kim, MO; Lee, BH; Lee, H, 1998) |
| "Suramin is an effective antitumor agent in hormone-refractory prostate cancer, but its mechanism(s) of action is not well understood." | 1.29 | Inhibition of fibroblast hyaluronic acid production by suramin. ( August, EM; Cysyk, RL; Duncan, KL; Malinowski, NM, 1993) |
| "Suramin is an anthelmintic drug that recently has been shown to have clinical efficacy in the treatment of patients with some advanced malignancies, including prostate carcinoma." | 1.29 | Effect of suramin on the mitogenic response of the human prostate carcinoma cell line PC-3. ( Ewing, MW; Gnarra, JR; Linehan, WM; Liu, SC; Meyers, CE; Walther, MM, 1993) |
| " After dosing with the D-compound, the highest levels of radioactivity were found in the liver, kidneys, thymus, thyroid gland, and central nervous system, including the brain." | 1.29 | Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat. ( Bertram, B; Bollow, U; Hull, WE; Pohl, J; Port, R; Schaper, M; Stüben, J; Wiessler, M, 1996) |
| "We observed that these three prostate cancer cell lines, which differed in their dependence on androgens for growth in vitro and in their in vivo behavior in nude mice, could be distinguished as follows: (a) androgen-sensitive LNCaP cells, which do not metastasize in nude mice, did not produce measurable amounts of bFGF, expressed small but measurable amounts of FGF receptor mRNA, and did respond to exogeneous bFGF; (b) androgen-insensitive, moderately metastatic DU 145 cells did produce measurable amounts of biologically active bFGF, expressed large amounts of FGF receptor mRNA, and responded to exogeneous bFGF and the heparin-binding fractions from DU 145 cell extracts; (c) androgen-insensitive and highly metastatic PC3 cells also produced measurable amounts of bFGF but did not demonstrate a growth response to either the heparin-binding fractions from PC3 cell extracts or exogenous bFGF, even though large amounts of FGF receptor mRNA were expressed in PC 3 cells." | 1.28 | Basic fibroblast growth factor in human prostate cancer cells. ( Chang, CS; Chodak, GW; Li, AK; Nakamoto, T, 1992) |
| " Growth in monolayer was initially inhibited in a dose-response fashion in the two androgen-independent cell lines, PC3 and DU145 but not in the androgen-dependent LNCaP cells." | 1.28 | Differential effects of transforming growth factor beta on human prostate cancer cells in vitro. ( Flanders, K; Gelmann, E; Knabbe, C; Wilding, G; Zugmeier, G, 1989) |
| "3H-thymidine incorporation was greater with human serum, with up to 120 per cent increase observed." | 1.26 | The effect of human serum on 3H-thymidine incorporation in human prostate tumors in tissue culture. ( Boileau, M; Hodges, CV; Keenan, E; Kemp, E; Lawson, R, 1978) |
| "The sera from patients with prostatic cancer have been observed to posses an unidentified factor capable of inhibiting the migration of leukocytes and the proliferative response to the nonspecific mitogen, phytohemagglutinin." | 1.25 | Serum proteins in prostatic cancer. II. Effect on in vitro cell-mediated immunologic responsiveness. ( Ablin, RJ; Bruns, GR; Bush, IM; Guinan, PD; Sadoughi, N, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (32.74) | 18.7374 |
| 1990's | 37 (32.74) | 18.2507 |
| 2000's | 34 (30.09) | 29.6817 |
| 2010's | 4 (3.54) | 24.3611 |
| 2020's | 1 (0.88) | 2.80 |
| Authors | Studies |
|---|---|
| Jagarlamudi, KK | 1 |
| L, S | 1 |
| M, Z | 1 |
| J, O | 1 |
| P, V | 1 |
| S, E | 1 |
| Dueregger, A | 1 |
| Guggenberger, F | 1 |
| Barthelmes, J | 1 |
| Stecher, G | 1 |
| Schuh, M | 1 |
| Intelmann, D | 1 |
| Abel, G | 1 |
| Haunschild, J | 1 |
| Klocker, H | 1 |
| Ramoner, R | 1 |
| Sampson, N | 1 |
| Lombardi, AP | 1 |
| Pisolato, R | 1 |
| Vicente, CM | 1 |
| Lazari, MF | 1 |
| Lucas, TF | 1 |
| Porto, CS | 1 |
| Thomas, F | 1 |
| Patel, S | 1 |
| Holly, JM | 1 |
| Persad, R | 1 |
| Bahl, A | 1 |
| Perks, CM | 1 |
| Lin, L | 1 |
| Sheng, J | 1 |
| Momin, RK | 1 |
| Du, Q | 1 |
| Huang, Z | 1 |
| Johnson, T | 1 |
| Ouhtit, A | 1 |
| Gaur, R | 1 |
| Fernando, A | 1 |
| Schwarzenberger, P | 2 |
| Su, J | 1 |
| Ismail, MF | 1 |
| El-Sayyad, HI | 1 |
| Karande, A | 1 |
| Elmageed, ZA | 1 |
| Rao, P | 1 |
| Raj, M | 1 |
| Katayama, H | 1 |
| Murashima, T | 1 |
| Saeki, Y | 1 |
| Nishizawa, Y | 1 |
| Louis, SN | 1 |
| Chow, L | 1 |
| Rezmann, L | 1 |
| Krezel, MA | 1 |
| Catt, KJ | 1 |
| Tikellis, C | 1 |
| Frauman, AG | 1 |
| Louis, WJ | 1 |
| Mémin, E | 1 |
| Yehia, G | 1 |
| Razavi, R | 1 |
| Molina, CA | 1 |
| Davila, M | 1 |
| Frost, AR | 1 |
| Grizzle, WE | 2 |
| Chakrabarti, R | 1 |
| Swamy, N | 2 |
| Persons, KS | 1 |
| Chen, TC | 3 |
| Ray, R | 2 |
| KATO, T | 1 |
| ISHIBE, T | 1 |
| HIRAYAMA, M | 1 |
| FUKUSHIGE, M | 1 |
| TAKENAKA, I | 1 |
| KAZUTA, M | 2 |
| Bhattacharyya, RS | 1 |
| Stern, PH | 1 |
| Sánchez, MG | 1 |
| Sánchez, AM | 1 |
| Ruiz-Llorente, L | 1 |
| Díaz-Laviada, I | 1 |
| Enomoto, M | 1 |
| Seong, JY | 1 |
| Kawashima, S | 1 |
| Park, MK | 1 |
| Bading, JR | 2 |
| Shahinian, AH | 2 |
| Vail, A | 1 |
| Bathija, P | 2 |
| Koszalka, GW | 1 |
| Koda, RT | 1 |
| Alauddin, MM | 1 |
| Fissekis, JD | 1 |
| Conti, PS | 2 |
| Hassan, S | 1 |
| Dobner, PR | 1 |
| Carraway, RE | 1 |
| Sanford, DC | 1 |
| DeWille, JW | 1 |
| Peleg, S | 1 |
| Dhawan, P | 1 |
| Christakos, S | 1 |
| Stewart, LV | 1 |
| Weigel, NL | 2 |
| Mehta, RG | 1 |
| Holick, MF | 2 |
| Bull, EE | 1 |
| Dote, H | 1 |
| Brady, KJ | 1 |
| Burgan, WE | 1 |
| Carter, DJ | 1 |
| Cerra, MA | 1 |
| Oswald, KA | 1 |
| Hollingshead, MG | 1 |
| Camphausen, K | 1 |
| Tofilon, PJ | 1 |
| Pandini, G | 1 |
| Mineo, R | 1 |
| Frasca, F | 1 |
| Roberts, CT | 1 |
| Marcelli, M | 1 |
| Vigneri, R | 1 |
| Belfiore, A | 1 |
| Moro, L | 2 |
| Arbini, AA | 2 |
| Marra, E | 2 |
| Greco, M | 2 |
| Sun, P | 1 |
| Xiong, H | 1 |
| Kim, TH | 1 |
| Ren, B | 1 |
| Zhang, Z | 1 |
| Drissi, A | 1 |
| Bennani, H | 1 |
| Giton, F | 1 |
| Charrouf, Z | 1 |
| Fiet, J | 1 |
| Adlouni, A | 1 |
| Agoulnik, IU | 1 |
| Vaid, A | 1 |
| Nakka, M | 1 |
| Alvarado, M | 1 |
| Bingman, WE | 1 |
| Erdem, H | 1 |
| Frolov, A | 1 |
| Smith, CL | 1 |
| Ayala, GE | 1 |
| Ittmann, MM | 1 |
| Alison, MR | 1 |
| Wright, NA | 1 |
| Meyer, JS | 1 |
| Sufrin, G | 1 |
| Martin, SA | 1 |
| Ware, JL | 1 |
| Paulson, DF | 1 |
| Webb, KS | 2 |
| Berdel, WE | 1 |
| Fink, U | 1 |
| Egger, B | 1 |
| Reichert, A | 1 |
| Munder, PG | 1 |
| Rastetter, J | 1 |
| Sandberg, AA | 1 |
| Heston, WD | 1 |
| Kadmon, D | 1 |
| Fair, WR | 1 |
| Wientjes, MG | 1 |
| Pretlow, TG | 1 |
| Badalament, RA | 1 |
| Burgers, JK | 1 |
| Au, JL | 1 |
| Loop, SM | 1 |
| Rozanski, TA | 1 |
| Ostenson, RC | 1 |
| Franzén, P | 1 |
| Ichijo, H | 1 |
| Miyazono, K | 1 |
| Rowley, DR | 1 |
| Dang, TD | 1 |
| McBride, L | 1 |
| Gerdes, MJ | 1 |
| Lu, B | 1 |
| Larsen, M | 1 |
| August, EM | 1 |
| Duncan, KL | 1 |
| Malinowski, NM | 1 |
| Cysyk, RL | 1 |
| Igawa, M | 1 |
| Tanabe, T | 1 |
| Chodak, GW | 2 |
| Rukstalis, DB | 1 |
| Shah, GV | 2 |
| Rayford, W | 2 |
| Noble, MJ | 2 |
| Austenfeld, M | 1 |
| Weigel, J | 2 |
| Vamos, S | 1 |
| Mebust, WK | 2 |
| Ewing, MW | 1 |
| Liu, SC | 1 |
| Gnarra, JR | 1 |
| Walther, MM | 1 |
| Meyers, CE | 1 |
| Linehan, WM | 1 |
| Hrzenjak, M | 1 |
| Shain, SA | 1 |
| Esquenet, M | 2 |
| Swinnen, JV | 2 |
| Heyns, W | 2 |
| Verhoeven, G | 2 |
| Stüben, J | 1 |
| Port, R | 1 |
| Bertram, B | 1 |
| Bollow, U | 1 |
| Hull, WE | 1 |
| Schaper, M | 1 |
| Pohl, J | 1 |
| Wiessler, M | 1 |
| Jamison, JM | 1 |
| Gilloteaux, J | 1 |
| Venugopal, M | 1 |
| Koch, JA | 1 |
| Sowick, C | 1 |
| Shah, R | 1 |
| Summers, JL | 1 |
| Myers, RB | 1 |
| Oelschlager, DK | 1 |
| Hockett, RD | 1 |
| Rogers, MD | 1 |
| Conway-Myers, BA | 1 |
| Austenfeld, MA | 1 |
| Jungwirth, A | 1 |
| Galvan, G | 1 |
| Pinski, J | 1 |
| Halmos, G | 1 |
| Szepeshazi, K | 1 |
| Cai, RZ | 1 |
| Groot, K | 1 |
| Schally, AV | 1 |
| Maramag, C | 1 |
| Menon, M | 1 |
| Balaji, KC | 1 |
| Reddy, PG | 1 |
| Laxmanan, S | 1 |
| Haberkorn, U | 1 |
| Bellemann, ME | 1 |
| Altmann, A | 1 |
| Gerlach, L | 1 |
| Morr, I | 1 |
| Oberdorfer, F | 1 |
| Brix, G | 1 |
| Doll, J | 1 |
| Blatter, J | 1 |
| van Kaick, G | 1 |
| Skryma, RN | 1 |
| Prevarskaya, NB | 1 |
| Dufy-Barbe, L | 1 |
| Odessa, MF | 1 |
| Audin, J | 1 |
| Dufy, B | 1 |
| Geller, J | 1 |
| Sionit, L | 1 |
| Partido, C | 1 |
| Li, L | 1 |
| Tan, X | 1 |
| Youngkin, T | 1 |
| Nachtsheim, D | 1 |
| Hoffman, RM | 1 |
| Bahk, JY | 1 |
| Hyun, JS | 1 |
| Lee, H | 1 |
| Kim, MO | 1 |
| Cho, GJ | 1 |
| Lee, BH | 1 |
| Choi, WS | 1 |
| Fornaro, M | 1 |
| Manzotti, M | 1 |
| Tallini, G | 1 |
| Slear, AE | 1 |
| Bosari, S | 1 |
| Ruoslahti, E | 1 |
| Languino, LR | 1 |
| Pflug, B | 1 |
| Djakiew, D | 1 |
| Lupowitz, Z | 2 |
| Zisapel, N | 3 |
| Mitchell, KO | 1 |
| El-Deiry, WS | 1 |
| Gilad, E | 1 |
| Laufer, M | 1 |
| Matzkin, H | 1 |
| Sintich, SM | 1 |
| Lamm, ML | 1 |
| Sensibar, JA | 1 |
| Lee, C | 2 |
| Jongsma, J | 1 |
| Oomen, MH | 1 |
| Noordzij, MA | 1 |
| Romijn, JC | 1 |
| van Der Kwast, TH | 1 |
| Schröder, FH | 1 |
| van Steenbrugge, GJ | 1 |
| Theodossiou, C | 1 |
| Schwartz, GG | 1 |
| Burnstein, KL | 1 |
| Lokeshwar, BL | 1 |
| Martin, JL | 1 |
| Pattison, SL | 1 |
| White, RA | 1 |
| Meistrich, ML | 1 |
| Pollack, A | 1 |
| Terry, NH | 1 |
| Matthews, E | 1 |
| Yang, T | 1 |
| Janulis, L | 1 |
| Goodwin, S | 1 |
| Kundu, SD | 1 |
| Karpus, WJ | 1 |
| Girnita, L | 1 |
| Girnita, A | 1 |
| Wang, M | 1 |
| Meis-Kindblom, JM | 1 |
| Kindblom, LG | 1 |
| Larsson, O | 1 |
| Yamabe, Y | 1 |
| Hoshino, A | 1 |
| Imura, N | 1 |
| Suzuki, T | 1 |
| Himeno, S | 1 |
| Hillman, GG | 1 |
| Forman, JD | 1 |
| Kucuk, O | 1 |
| Yudelev, M | 1 |
| Maughan, RL | 1 |
| Rubio, J | 1 |
| Layer, A | 1 |
| Tekyi-Mensah, S | 1 |
| Abrams, J | 1 |
| Sarkar, FH | 1 |
| Rylova, SN | 1 |
| Amalfitano, A | 1 |
| Persaud-Sawin, DA | 1 |
| Guo, WX | 1 |
| Chang, J | 1 |
| Jansen, PJ | 1 |
| Proia, AD | 1 |
| Boustany, RM | 1 |
| Rho, YS | 1 |
| Kim, SA | 1 |
| Jung, JC | 1 |
| Shin, CC | 1 |
| Chang, SG | 1 |
| Rimler, A | 1 |
| Li, MT | 1 |
| Richter, F | 1 |
| Chang, C | 1 |
| Irwin, RJ | 1 |
| Huang, H | 1 |
| Claflin, AJ | 1 |
| Vesely, DL | 1 |
| Hudson, JL | 1 |
| Bagwell, CB | 1 |
| Lehotay, DC | 1 |
| Lo, TM | 1 |
| Fletcher, MA | 1 |
| Block, NL | 1 |
| Levey, GS | 1 |
| Boileau, M | 1 |
| Keenan, E | 1 |
| Kemp, E | 1 |
| Lawson, R | 1 |
| Hodges, CV | 1 |
| Lasnitzki, I | 1 |
| Ablin, RJ | 4 |
| Guinan, PD | 3 |
| Bruns, GR | 3 |
| Sadoughi, N | 1 |
| Bush, IM | 4 |
| Al sheik, H | 1 |
| Limonta, P | 1 |
| Dondi, D | 1 |
| Moretti, RM | 1 |
| Maggi, R | 1 |
| Motta, M | 1 |
| Touffet, S | 1 |
| Gayet, G | 1 |
| Sampérez, S | 1 |
| Jouan, P | 1 |
| Chen, HZ | 1 |
| Kirschenbaum, A | 1 |
| Mandeli, J | 1 |
| Hollander, VP | 1 |
| Perkel, VS | 1 |
| Mohan, S | 1 |
| Herring, SJ | 1 |
| Baylink, DJ | 1 |
| Linkhart, TA | 1 |
| Nakamoto, T | 1 |
| Chang, CS | 1 |
| Li, AK | 1 |
| MacDonald, A | 1 |
| Habib, FK | 1 |
| Hayashi, N | 1 |
| Cunha, GR | 1 |
| Mobbs, BG | 1 |
| Johnson, IE | 1 |
| Pavelić, J | 1 |
| Zgradić, I | 1 |
| Pavelić, K | 1 |
| Donaldson, JT | 1 |
| Tucker, JA | 1 |
| Keane, TE | 1 |
| Walther, PJ | 1 |
| Koutsilieris, M | 1 |
| Rabbani, SA | 1 |
| Goltzman, D | 1 |
| Hierowski, MT | 1 |
| McDonald, MW | 1 |
| Dunn, L | 1 |
| Sullivan, JW | 1 |
| Kirchheimer, JC | 1 |
| Wojta, J | 1 |
| Hienert, G | 1 |
| Christ, G | 1 |
| Heger, ME | 1 |
| Pflüger, H | 1 |
| Binder, BR | 1 |
| Kyprianou, N | 1 |
| Isaacs, JT | 1 |
| Wilding, G | 1 |
| Zugmeier, G | 1 |
| Knabbe, C | 1 |
| Flanders, K | 1 |
| Gelmann, E | 1 |
| Citterio, F | 1 |
| Kahan, BD | 1 |
| Scott, FM | 1 |
| Sator de Serrano, V | 1 |
| Castellino, FJ | 1 |
| Feminell, JG | 1 |
| Tomashefsky, P | 1 |
| Tannenbaum, M | 1 |
| Lattimer, JK | 1 |
| Faul, P | 3 |
| Rabes, H | 3 |
| Helpap, B | 2 |
| Stiens, R | 2 |
| Brühl, P | 1 |
| Burns, GR | 1 |
| Guinan, P | 1 |
| McLaughlin, AP | 1 |
| Brooks, JD | 1 |
| Markewitz, M | 2 |
| Veenema, RJ | 3 |
| Fingerhut, B | 3 |
| Gursel, E | 1 |
| Huber, C | 1 |
| Huber, H | 1 |
| Gföller, A | 1 |
| Michlamyr, G | 1 |
| Braunsteiner, H | 1 |
| Mackler, MA | 1 |
| Liberti, JP | 1 |
| Smith, MJ | 1 |
| Koontz, WW | 1 |
| Prout, GR | 1 |
| Robinson, MR | 2 |
| Nakhla, LS | 2 |
| Whitaker, RH | 2 |
| Chandley, AC | 1 |
| Kofman-Alfaro, S | 1 |
| Nehme-Haily, D | 1 |
| Sommers, SC | 1 |
| Graff, S | 1 |
| Butler, MP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Non Interventional Post Authorisation Multicenter Study to Evaluate the Disease Control (Benign Prostate Hyperplasia Control) and Quality of Life (QoL) Following the 6-months Combination Treatment With Dutasteride and Tamsulosin. PROSPERITY Group of Stu[NCT04831476] | 1,296 participants (Actual) | Observational | 2021-09-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for thymidine and Prostatic Neoplasms
| Article | Year |
|---|---|
Prostate cancer. Growth kinetics.
Topics: Adenocarcinoma; Animals; Cell Division; DNA Replication; DNA, Neoplasm; Humans; Jejunum; Kinetics; M | 1981 |
[Demonstration of thymidine phosphorylase activity in human healthy, adenomatous and cancerous prostate].
Topics: Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Thymidine; Thymidine Phosphoryla | 1992 |
111 other studies available for thymidine and Prostatic Neoplasms
| Article | Year |
|---|---|
Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.
Topics: Antibodies, Monoclonal; Biomarkers, Tumor; Breast Neoplasms; DNA; Enzyme-Linked Immunosorbent Assay; | 2022 |
Attenuation of nucleoside and anti-cancer nucleoside analog drug uptake in prostate cancer cells by Cimicifuga racemosa extract BNO-1055.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Bromodeoxyuridine; Cell Line; Ce | 2013 |
Estrogen receptor beta (ERβ) mediates expression of β-catenin and proliferation in prostate cancer cell line PC-3.
Topics: beta Catenin; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin D2; Cycloheximide; Estradiol; | 2016 |
Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitor.
Topics: Blotting, Western; Catechin; Cell Death; Cell Line, Tumor; Dihydrotestosterone; DNA Replication; DNA | 2009 |
Facile synthesis and anti-tumor cell activity of Se-containing nucleosides.
Topics: Cell Line, Tumor; Cells, Cultured; Deoxyuridine; Drug Screening Assays, Antitumor; Humans; Male; Pro | 2009 |
Biochemical characterization of riboflavin carrier protein (RCP) in prostate cancer.
Topics: Amino Acid Sequence; Blotting, Western; Cell Line, Tumor; Humans; Immunohistochemistry; Immunoprecip | 2009 |
The pure anti-androgen bicalutamide inhibits cyclin A expression both in androgen-dependent and -independent cell lines.
Topics: Androgen Antagonists; Androgens; Anilides; Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tu | 2010 |
Expression and function of ATIP/MTUS1 in human prostate cancer cell lines.
Topics: Cell Line, Tumor; DNA Primers; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Huma | 2010 |
ICER reverses tumorigenesis of rat prostate tumor cells without affecting cell growth.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Biological Assay; Blotting, Western; Cell Cycle; Ce | 2002 |
LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer.
Topics: Actin Depolymerizing Factors; Cell Division; Cell Line; Cell Line, Tumor; Cell Separation; DNA; DNA- | 2003 |
1alpha,25-Dihydroxyvitamin D3-3beta-(2)-bromoacetate, an affinity labeling derivative of 1alpha,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells.
Topics: Affinity Labels; Apoptosis; Breast Neoplasms; Calcitriol; Cell Division; Cell Line; Cell Survival; D | 2003 |
BASIC STUDIES ON THE PROSTATE OF RAT UNDER VARIOUS HORMONAL ENVIRONMENT.
Topics: Alloxan; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Cortisone; Estradio | 1965 |
IGF-I and MAP kinase involvement in the stimulatory effects of LNCaP prostate cancer cell conditioned media on cell proliferation and protein synthesis in MC3T3-E1 osteoblastic cells.
Topics: Animals; Cell Division; Culture Media, Conditioned; Enzyme Inhibitors; Humans; Insulin-Like Growth F | 2003 |
Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells.
Topics: Androgen Receptor Antagonists; Arachidonic Acids; Cannabinoids; Cell Division; Cell Line, Tumor; DNA | 2003 |
Proliferation of TSU-Pr1, a human prostatic carcinoma cell line is stimulated by gonadotropin-releasing hormone.
Topics: Cell Division; Colony-Forming Units Assay; Culture Media, Conditioned; Fertility Agents, Female; Gon | 2004 |
Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.
Topics: Adenocarcinoma; Animals; Arabinofuranosyluracil; Carbon Radioisotopes; Cell Line, Tumor; Colorectal | 2004 |
Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells.
Topics: Blotting, Western; DNA, Neoplasm; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Humans; Liga | 2004 |
C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
Topics: Binding Sites; Blotting, Northern; Blotting, Western; CCAAT-Enhancer-Binding Protein-delta; CCAAT-En | 2005 |
Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Animals; Apoptosis; Calcitriol; Carrier Proteins; Caspases | 2004 |
Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin.
Topics: Administration, Oral; Animals; Benzoquinones; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Com | 2004 |
Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Cell Line, Tumor; Cell Mov | 2005 |
Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation.
Topics: BRCA2 Protein; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Collagen Type I; DNA; DNA Repair | 2005 |
Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Cell Proliferation; Endothelin | 2006 |
Tocopherols and saponins derived from Argania spinosa exert, an antiproliferative effect on human prostate cancer.
Topics: 2-Methoxyestradiol; Antioxidants; Cell Proliferation; Estradiol; Humans; Male; Neoplasms, Hormone-De | 2006 |
Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.
Topics: Androgens; Cell Line, Tumor; Cell Proliferation; Exons; Humans; Immunohistochemistry; Introns; Male; | 2006 |
Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2.
Topics: BRCA2 Protein; Cell Adhesion; Cell Division; Cell Line, Tumor; Enzyme Activation; Extracellular Sign | 2007 |
[DNA metabolism of prostate. II. DNA metabolism of experimental prostatic tumors].
Topics: Animals; Autoradiography; DNA; Male; Methylcholanthrene; Neoplasms, Experimental; Prostatic Neoplasm | 1966 |
Proliferative activity of benign human prostate, prostatic adenocarcinoma and seminal vesicle evaluated by thymidine labeling.
Topics: Adenocarcinoma; Aged; Autoradiography; Cell Division; Cell Nucleus; Humans; Male; Prostate; Prostati | 1982 |
1,10-Phenanthroline reversibility inhibits proliferation of two human prostate carcinoma cell lines (PC-3 and DU145).
Topics: Antigens, Surface; Cell Division; Cell Line; DNA Replication; Epitopes; Humans; Kinetics; Male; Phen | 1984 |
Inhibition by alkyl-lysophospholipids of tritiated thymidine uptake in cells of human malignant urologic tumors.
Topics: Cell Division; Cells, Cultured; Humans; Lysophosphatidylcholines; Male; Prostatic Neoplasms; Teratom | 1981 |
Rationale and practice of testing chemotherapeutic agents for prostate cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adenocarcinoma; Animals; Antineoplastic Agents; Arginase; DNA | 1981 |
Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumor.
Topics: Animals; Diethylstilbestrol; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasms, Experimental; Pi | 1981 |
Histocultures of human prostate tissues for pharmacologic evaluation.
Topics: Acid Phosphatase; Cell Division; Culture Techniques; Drug Screening Assays, Antitumor; Humans; Immun | 1995 |
Human primary prostate tumor cell line, ALVA-31: a new model for studying the hormonal regulation of prostate tumor cell growth.
Topics: Acid Phosphatase; Animals; Biomarkers; Cell Division; Cytosol; Female; Humans; Isoenzymes; Karyotypi | 1993 |
Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells.
Topics: Cell Division; Clone Cells; Drug Resistance; Fibronectins; Fibrosis; Genes, jun; Humans; Male; Plasm | 1993 |
Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action.
Topics: beta 2-Microglobulin; Cell Division; Culture Media; Humans; Kinetics; Male; Mitogens; Prostate; Pros | 1995 |
Inhibition of fibroblast hyaluronic acid production by suramin.
Topics: 3T3 Cells; Animals; Cell Division; Culture Media; DNA; Dose-Response Relationship, Drug; Fibroblasts | 1993 |
N-(4-hydroxyphenyl) retinamide induces cell cycle specific growth inhibition in PC3 cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Blotting, Northern; Cell Cycle; Cell Division; Cell Line; DNA | 1994 |
Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3',5'-monophosphates and cytoplasmic Ca2+ transients.
Topics: Adenocarcinoma; Calcitonin; Calcium; Cell Division; Cell Line; Cell Membrane; Cyclic AMP; Cytoplasm; | 1994 |
Effect of suramin on the mitogenic response of the human prostate carcinoma cell line PC-3.
Topics: Blotting, Northern; Cell Cycle; Cell Division; Culture Media, Serum-Free; Dose-Response Relationship | 1993 |
Protein kinase C-dependent and -independent pathways of signal transduction in prostate cancer cells: fibroblast growth factor utilization of a protein kinase C-independent pathway.
Topics: Animals; Cell Division; Down-Regulation; Fibroblast Growth Factor 1; Fibroblast Growth Factors; Male | 1995 |
Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.
Topics: Androgens; Antimetabolites, Antineoplastic; Calcitriol; Cell Differentiation; Cell Division; Humans; | 1996 |
Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat.
Topics: Animals; Antineoplastic Agents; Autoradiography; Bile; DNA, Neoplasm; Female; Glucose; Half-Life; Hu | 1996 |
Flow cytometric and ultrastructural aspects of the synergistic antitumor activity of vitamin C-vitamin K3 combinations against human prostatic carcinoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; DNA; Drug Synergism; Flow Cytometry; | 1996 |
The effects of dihydrotestosterone on the expression of p185(erbB-2) and c-erbB-2 mRNA in the prostatic cell line LNCaP.
Topics: Dihydrotestosterone; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms; Prot | 1996 |
Muscarinic cholinergic receptors promote growth of human prostate cancer cells.
Topics: Bromodeoxyuridine; Carbachol; DNA, Neoplasm; Humans; Immunohistochemistry; Male; Prostatic Neoplasms | 1997 |
Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice.
Topics: Animals; Antineoplastic Agents; Bombesin; Cell Division; DNA, Neoplasm; Drug Combinations; ErbB Rece | 1997 |
Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis.
Topics: Androgens; Antineoplastic Agents; Ascorbic Acid; Azides; Cell Count; Cell Survival; DNA, Neoplasm; D | 1997 |
PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Biological Transport; Deoxycytidine; Deoxy | 1997 |
Potassium conductance in the androgen-sensitive prostate cancer cell line, LNCaP: involvement in cell proliferation.
Topics: Androgens; Apoptosis; Calcium; Cell Division; Elapid Venoms; Humans; Male; Membrane Potentials; Patc | 1997 |
LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids.
Topics: Acid Phosphatase; Calcitriol; Carrier Proteins; Cell Division; Diazepam Binding Inhibitor; ErbB Rece | 1997 |
Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture.
Topics: Antineoplastic Agents; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Genistein; | 1998 |
Expression of gonadotropin-releasing hormone (GnRH) and GnRH receptor mRNA in prostate cancer cells and effect of GnRH on the proliferation of prostate cancer cells.
Topics: Cell Division; Gene Expression; Gonadotropin-Releasing Hormone; Humans; In Situ Hybridization; Male; | 1998 |
Beta1C integrin in epithelial cells correlates with a nonproliferative phenotype: forced expression of beta1C inhibits prostate epithelial cell proliferation.
Topics: Alternative Splicing; Bile Ducts; Cell Division; Embryonic and Fetal Development; Epithelial Cells; | 1998 |
Expression of p75NTR in a human prostate epithelial tumor cell line reduces nerve growth factor-induced cell growth by activation of programmed cell death.
Topics: Apoptosis; Cell Division; Humans; Male; Nerve Growth Factors; Prostatic Neoplasms; Receptor, Nerve G | 1998 |
Hormonal interactions in human prostate tumor LNCaP cells.
Topics: Androgens; Cell Division; Cell Survival; Drug Interactions; Estradiol; Humans; Male; Melatonin; Neop | 1999 |
Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.
Topics: Adenoviridae; Apoptosis; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Cycl | 1999 |
Melatonin receptors in PC3 human prostate tumor cells.
Topics: Binding Sites; Cell Count; Cell Survival; Cholera Toxin; Cyclic AMP; Cyclic AMP-Dependent Protein Ki | 1999 |
Transforming growth factor-beta1-induced proliferation of the prostate cancer cell line, TSU-Pr1: the role of platelet-derived growth factor.
Topics: Becaplermin; Cell Division; DNA, Neoplasm; Humans; Kinetics; Male; Platelet-Derived Growth Factor; P | 1999 |
Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines.
Topics: Androgens; Cell Division; Cyclic AMP; Dideoxyadenosine; Enzyme Inhibitors; Gastrin-Releasing Peptide | 2000 |
Propylthiouracil reduces xenograft tumor growth in an athymic nude mouse prostate cancer model.
Topics: Animals; Antimetabolites, Antineoplastic; Contrast Media; Disease Models, Animal; Humans; Hypothyroi | 2000 |
The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Topics: Calcifediol; Cell Count; Cell Division; Chloramphenicol O-Acetyltransferase; Dose-Response Relations | 2000 |
Insulin-like growth factor binding protein-3 is regulated by dihydrotestosterone and stimulates deoxyribonucleic acid synthesis and cell proliferation in LNCaP prostate carcinoma cells.
Topics: Cell Division; Dihydrotestosterone; DNA; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Combi | 2000 |
Pharmacokinetics of the thymidine analog 2'-fluoro-5-[(14)C]-methyl-1-beta-D-arabinofuranosyluracil ([(14)C]FMAU) in rat prostate tumor cells.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; DNA; Male; Prostatic Neoplasms; Rats; Thymidine; | 2000 |
Simultaneous estimation of T(G2+M), T(S), and T(pot) using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Bromodeoxyuridine; DNA, Neoplasm; Female | 2000 |
Down-regulation of TGF-beta1 production restores immunogenicity in prostate cancer cells.
Topics: Animals; Cell Division; Cloning, Molecular; Disease Progression; DNA, Complementary; Down-Regulation | 2000 |
A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Bone Neoplasms; Cell Cycle; Cell Division; Chromosomes, Huma | 2000 |
Enhancement of androgen-dependent transcription and cell proliferation by tributyltin and triphenyltin in human prostate cancer cells.
Topics: Androgen Antagonists; Androgens; Blotting, Northern; Cell Division; DNA, Neoplasm; Flutamide; Humans | 2000 |
Genistein potentiates the radiation effect on prostate carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cell Survival; DNA; DNA, Neoplasm; Gamma Rays; Geni | 2001 |
The CLN3 gene is a novel molecular target for cancer drug discovery.
Topics: Adenoviridae; Animals; Apoptosis; Ceramides; Colonic Neoplasms; DNA, Antisense; Gene Expression Regu | 2002 |
Anticancer cytotoxicity and nephrotoxicity of the new platinum (II) complexes containing diaminocyclohexane and glycolic acid.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Coloring Agents; Cyclohexanes; DNA; Female; Glucose | 2002 |
Differential regulation by melatonin of cell growth and androgen receptor binding to the androgen response element in prostate cancer cells.
Topics: Antioxidants; Cell Cycle; DNA; Electrophoresis; Flow Cytometry; Humans; Male; Melatonin; Mutation; P | 2002 |
Androgen and retinoic acid interaction in LNCaP cells, effects on cell proliferation and expression of retinoic acid receptors and epidermal growth factor receptor.
Topics: Dose-Response Relationship, Drug; Drug Interactions; Electrophoretic Mobility Shift Assay; ErbB Rece | 2002 |
Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata).
Topics: Adenocarcinoma; Animals; Cell Cycle; Concanavalin A; Cyclic GMP; Guanylate Cyclase; In Vitro Techniq | 1978 |
The effect of human serum on 3H-thymidine incorporation in human prostate tumors in tissue culture.
Topics: Animals; Blood; Cattle; Culture Techniques; Dihydrotestosterone; DNA; Humans; Male; Prostatic Hyperp | 1978 |
Reversal of methylcholanthrene-induced changes in mouse prostates in vitro by retinoic acid and its analogues.
Topics: Animals; DNA; Hyperplasia; In Vitro Techniques; Male; Metaplasia; Methylcholanthrene; Mice; Mice, In | 1976 |
Serum proteins in prostatic cancer. II. Effect on in vitro cell-mediated immunologic responsiveness.
Topics: Antilymphocyte Serum; Blood Proteins; Cell Migration Inhibition; Cells, Cultured; Culture Media; Hum | 1975 |
Hormonal therapy and alteration of lymphocyte proliferation.
Topics: Estrogens; Humans; Lectins; Lymphocyte Activation; Lymphocytes; Male; Penile Induration; Prostatic N | 1976 |
Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP.
Topics: Antineoplastic Agents; Binding Sites; Buserelin; Gonadotropin-Releasing Hormone; Goserelin; Humans; | 1992 |
The effect of dihydrotestosterone and culture conditions on proliferation of the human prostatic cancer cell line LNCaP.
Topics: Biological Factors; Cell Count; Cell Division; Culture Media, Serum-Free; Dihydrotestosterone; Human | 1992 |
Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.
Topics: Animals; Bone and Bones; Cell Division; Cells, Cultured; Chromatography, Gel; Culture Media; Dextran | 1990 |
Basic fibroblast growth factor in human prostate cancer cells.
Topics: 3T3 Cells; Animals; Biological Assay; Blotting, Northern; Blotting, Southern; Cattle; Cell Division; | 1992 |
Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines.
Topics: Blotting, Western; Cell Division; DNA, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Humans; Ma | 1992 |
Mesenchyme-induced changes in the neoplastic characteristics of the Dunning prostatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Cell Differentiation; Cell Division; Cells, Cultured; Electrophoresis, Poly | 1991 |
Suppression of the growth of the androgen-insensitive R3327 HI rat prostatic carcinoma by combined estrogen and antiprogestin treatment.
Topics: Animals; Cell Division; Cell Line; Diethylstilbestrol; DNA Replication; Drug Interactions; Male; Mif | 1991 |
Presence of oestrogen receptors on target cells and antiproliferative activity of estramustine phosphate: positive correlation for human tumours in vitro.
Topics: Cell Division; Cytosol; DNA, Neoplasm; Dose-Response Relationship, Drug; Estramustine; Female; Human | 1991 |
Characterization of a new model of human prostatic cancer: the multicellular tumor spheroid.
Topics: Antineoplastic Agents; Cell Line; Cell Separation; Drug Screening Assays, Antitumor; Flow Cytometry; | 1990 |
Selective osteoblast mitogens can be extracted from prostatic tissue.
Topics: Adenocarcinoma; Animals; Cell Division; Cell Line; Fibroblasts; Growth Substances; Humans; Male; Mit | 1986 |
The partial dependency of human prostatic growth factor on steroid hormones in stimulating thymidine incorporation into DNA.
Topics: Adult; Aged; Dihydrotestosterone; DNA; DNA, Neoplasm; Electrophoresis, Polyacrylamide Gel; Estradiol | 1987 |
Effect of urokinase on the proliferation of primary cultures of human prostatic cells.
Topics: Cell Division; Cells, Cultured; DNA Replication; Fibrinolysin; Humans; Kinetics; Male; Prostate; Pro | 1987 |
"Thymineless" death in androgen-independent prostatic cancer cells.
Topics: Animals; Blotting, Northern; Cell Line; Cell Survival; DNA, Neoplasm; Drug Screening Assays, Antitum | 1989 |
Differential effects of transforming growth factor beta on human prostate cancer cells in vitro.
Topics: Androgens; Cell Adhesion; Cell Division; Humans; Male; Prostatic Neoplasms; Protein Biosynthesis; Pr | 1989 |
Specificity of the nuclear effect of cyclosporine on the immune cells.
Topics: Adenocarcinoma; Animals; Cell Line; Cell Nucleus; Cyclosporins; DNA Replication; Kidney; Liver; Lymp | 1989 |
Appearance of plasminogen activator activity during a synchronous cycle of a rat adenocarcinoma cell line, PA-III.
Topics: Adenocarcinoma; Animals; Cell Cycle; Cell Line; Clone Cells; DNA Replication; Hydroxyurea; Kinetics; | 1987 |
Differences in regeneration of the prostate after cryoprostatectomy, fulguration and excision.
Topics: Animals; Autoradiography; Cryosurgery; DNA; Electrosurgery; Male; Metaplasia; Organ Size; Prostate; | 1970 |
[Thymidine- 3 H autoradiography of human prostate cytological biopsy specimens].
Topics: Autoradiography; Biopsy, Needle; Carcinoma; Culture Techniques; Diethylstilbestrol; DNA; Glycogen; H | 1972 |
[Autoradiographic in vitro investigations on prostatic tissue with the C-14- und H-3-thymidine double-labeling method (author's transl)].
Topics: Adenocarcinoma; Aged; Atrophy; Autoradiography; Biopsy, Needle; Carbon Radioisotopes; Carcinoma; DNA | 1974 |
Letter: Afferent blockage, oestrogenic therapy, and malignancy.
Topics: Adult; Cell Transformation, Neoplastic; Estrogens; Female; Humans; Immunity, Cellular; Lectins; Lymp | 1974 |
[Determination of proliferative activity of human prostatic needle biopsies by means of 3H-thymidine autoradiography (author's transl)].
Topics: Autoradiography; Biopsy, Needle; Carcinoma; Cell Division; Cells, Cultured; Humans; Male; Prostatic | 1973 |
Antiandrogenic suppression of lymphocytic blastogenesis: in vitro and in vivo observations.
Topics: Adolescent; Adult; Androgen Antagonists; Antibody Formation; Cell Transformation, Neoplastic; Diethy | 1974 |
[The significance of cell kinetics in the treatment of malignant tumours (author's transl)].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Autoradiography; Bronchial Neoplasms; Carcinoma, Squ | 1974 |
A plasma factor inhibiting lymphocyte reactivity in urologic cancer patients.
Topics: Adenocarcinoma; Analysis of Variance; Cells, Cultured; Female; Humans; Immune Sera; Immunity, Cellul | 1974 |
[Thymidine-3H autoradiography in human cytological prostate puncture material].
Topics: Autoradiography; Biopsy, Needle; Humans; Male; Prostatic Neoplasms; Thymidine; Tritium | 1972 |
Testicular morphology and germ cell DNA synthesis in the testis of patients with prostatic carcinoma.
Topics: Acid Phosphatase; Aged; Atrophy; Biopsy; Carcinoma; DNA; Follicle Stimulating Hormone; Gonadotropins | 1971 |
[DNS synthesizing lymphocytes in patients with carcinoma].
Topics: Autoradiography; Blood Cell Count; Breast Neoplasms; Bronchial Neoplasms; DNA, Neoplasm; Female; His | 1971 |
The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
Topics: Castration; Diethylstilbestrol; Humans; Male; Prostatic Neoplasms; Protein Binding; Testis; Testoste | 1972 |
Lymphocyte transformation inb carcinoma of the prostate.
Topics: Acid Phosphatase; Aged; Culture Techniques; Humans; Lectins; Lymphocyte Activation; Lymphocytes; Mal | 1971 |
"Unscheduled" DNA synthesis in human germ cells following UV irradiation.
Topics: Adult; Aged; Autoradiography; Biopsy; Cells, Cultured; DNA; Histocytochemistry; Humans; Male; Meiosi | 1971 |
A new concept in the management of carcinoma of the prostate.
Topics: Aged; Biopsy; Carcinoma; Humans; Immune Sera; Immunization, Passive; Lectins; Lymphocyte Activation; | 1971 |
Cyproterone acetate (SH 714) effect on histology and nucleic acid synthesis in the testes of patients with prostatic carcinoma. A preliminary report.
Topics: Adenocarcinoma; Aged; Biopsy; DNA; Humans; Leydig Cells; Male; Nucleic Acids; Progestins; Prostatic | 1969 |
Observations on RNA in prostate and bladder neoplasms.
Topics: Animals; Histocytochemistry; Humans; In Vitro Techniques; Male; Nucleosides; Prostatic Neoplasms; Ra | 1969 |